To explore the clinical efficacy of modified Shenling Baizhu powder combined with mesalazine in the treatment of mild to moderate ulcerative colitis (UC) with spleen deficiency and dampness accumulation syndrome.
A total of 70 patients with mild to moderate UC with spleen deficiency and dampness accumulation syndrome admitted to the outpatient and ward of the department of spleen and stomach diseases of Jiangyin Hospital of Traditional Chinese Medicine and Jiangsu Province Hospital of Traditional Chinese Medicine from October 2023 to December 2024 were selected and divided into control group and treatment group according to the random number table method, with 35 cases in each group. The control group was treated with mesalazine, while the treatment group was treated with the modified formula of Shenling Baizhu Powder in addition to the treatment of control group. Both groups were treated for 24 weeks. The total effective rate, symptom score, colonoscopy mucosal lesion scores, and iron death related factors were compared between the two groups.
The total effective rate of the treatment group was better than that of the control group (94.29% vs. 82.86%, P<0.05). After treatment, the average symptom scores, colonic mucosal lesion scores and serum ferrous ion of the two groups decreased significantly (P<0.05). The levels of serum superoxide dismutase, glutathione and glutathione peroxidase 4 increased significantly (P<0.05). The improvement of diarrhea, abdominal distension, abdominal pain, limb drowsiness and anorexia in the treatment group were better than those in the control group (P<0.05). There was no statistically significant difference in the improvement of purulent bloody stool and colonic mucosal lesions between the two groups (P>0.05). No significant adverse reactions were observed in the two groups during treatment.
The modified Shenling Baizhu powder has a remarkable therapeutic effect on patients with mild to moderate UC with spleen deficiency and dampness accumulation syndrome, and it has good safety and high clinical application value.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |